Results 161 to 170 of about 37,430 (216)

A Simulation-Based Assessment of Dosage Regimen Appropriateness for Multiple Myeloma Medicines Reflecting Demographic and Ethnic Differences. [PDF]

Clin Transl Sci
Kang M, Choi S, Park SS, Han S, Han S.
europepmc   +1 more source

Lenalidomide monotherapy for necrobiotic xanthogranuloma. [PDF]

JAAD Case Rep
Huntsman A, McClure E, Fett N.
europepmc   +1 more source

A bibliometric analysis of the research landscape of lenalidomide resistance in multiple myeloma. [PDF]

Discov Oncol
Li R, Huang L, Hao Z, Zhao X, Dai J, Gao Q, Gao Y.   +6 more
europepmc   +1 more source

The synthetic landscape of cereblon (CRBN) binders: from thalidomide to emerging chemotypes.

Chem Soc Rev
Rafael S, Sánchez-Zarzalejo C, Whelan R, Harris C, Verdaguer X, Mayor-Ruiz C, Riera A.   +6 more
europepmc   +1 more source

Commentary: Rituximab combined with lenalidomide for the treatment of marginal zone lymphoma with IgM kappa positivity and cold agglutinin syndrome: a case report. [PDF]

Front Immunol
Wang Z, Wang C, Wang X, Tang B.
europepmc   +1 more source

Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma. [PDF]

N Engl J Med
Kumar S, Jacobus S, Cohen A, Weiss M, Callander N, Singh A, Parker T, Green M, Thertulien R, Parsons B, Kumar P, Kapoor P, Rosenberg A, Dib E, Almquist D, Zonder J, Faber E, Wei Z, Anderson K, Lonial S, Richardson P, Orlowski R, Wagner L, Rajkumar SV.   +23 more
europepmc   +1 more source

Frontline daratumumab, lenalidomide, and dexamethasone in patients older than 80 years with newly diagnosed multiple myeloma: treatment durability, infectious complications, and nutritional vulnerability. [PDF]

Blood Res
Horigome Y, Ehata K, Tadera N, Hayama K, Kamata H, Suzuki T, Miyazaki K.   +6 more
europepmc   +1 more source

Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma. [PDF]

Cancer
Worth HA, Costa LJ.
europepmc   +1 more source

Phase 1 study of zanubrutinib plus lenalidomide for patients with relapsed/refractory diffuse large B-cell lymphoma. [PDF]

Blood Adv
Song Z, Cheng Y, Yang H, Zhang L, Zou L, Guo Y, Cao J, Huang H, Wang Z, Huang S, Fang Y, Lyu J, Zhang Y, Liu Y, Zhou K, Zhang H.   +15 more
europepmc   +1 more source